Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Keynote Address at the ASBrS 2022 Annual Meeting Low-Risk Breast Cancer: When Is Local Therapy Enough?
V. Suzanne Klimberg
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Keynote Address at the ASBrS 2022 Annual Meeting Low-Risk Breast Cancer: When Is Local Therapy Enough?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Keynote Address
100%
Local Therapy
100%
Endocrine Therapy
100%
Low-risk Breast Cancer
100%
Adverse Effects
50%
Breast Cancer Treatment
50%
Chemotherapy
50%
Quality of Life
50%
Quality of Life Improvement
50%
Breast Cancer Patients
50%
Long-term Survival
50%
Local Recurrence
50%
21-gene Recurrence Score
50%
Young Patients
50%
Local Treatment
50%
Recurrence Score
50%
Adjuvant Endocrine Therapy
50%
MammaPrint
50%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Breast Cancer
100%
Endocrine Therapy
100%
Adverse Event
33%
Chemotherapy
33%
Long Term Survival
33%